XML 11 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Unaudited Condensed Consolidated Interim Income Statement - GBP (£)
£ in Millions
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Profit or loss [abstract]    
Revenue £ 6,132.5 £ 5,582.7 [1],[2]
Costs of services (5,196.1) (4,804.7) [2]
Gross profit 936.4 778.0 [2]
General and administrative costs (452.8) (3,528.6) [2]
Operating profit/(loss) 483.6 (2,750.6) [2]
Share of results of associates 40.0 (51.9) [2]
Profit/(loss) before interest and taxation 523.6 (2,802.5) [2]
Finance and investment income 30.1 51.2 [2]
Finance costs (147.2) (157.3) [2]
Revaluation and retranslation of financial instruments (12.1) (268.6) [2]
Profit/(loss) before taxation 394.4 (3,177.2) [2]
Taxation (107.1) (10.9) [2]
Profit/(loss) for the period from continuing operations 287.3 (3,188.1) [2]
Profit for the period from discontinued operations [2]   3.1
Profit/(loss) for the period 287.3 (3,185.0) [2]
Attributable to:    
Continuing operations 252.7 (3,209.2) [2]
Discontinued operations [2]   (6.8)
Total Equity holders of the parent 252.7 (3,216.0) [2]
Continuing operations 34.6 21.1 [2]
Discontinued operations [2]   9.9
Non-controlling interests 34.6 31.0 [2]
Profit/(loss) for the period £ 287.3 £ (3,185.0) [2]
Earnings per share    
Basic earnings per ordinary share £ 0.209 £ (2.625) [2]
Diluted earnings per ordinary share 0.206 (2.625) [2]
Basic earnings (loss) per share from continuing operations 0.209 (2.620) [2]
Diluted earnings (loss) per share from continuing operations £ 0.206 £ (2.620) [2]
[1] During 2020, the Group announced the intention to combine Grey and AKQA into AKQA Group, and to bring Geometry and GTB into VMLY&R, and International Healthcare into VMLY&R and Ogilvy. As a result AKQA, Geometry, GTB and International Healthcare are now reported within Global Integrated Agencies, having previously been reported within Specialist Agencies. Prior year figure have been re-presented to reflect these changes.
[2] Figures have been restated as described in the accounting policies.